Mirion Technologies to Provide Dosimetry System to Swedish Rescue Service
* Reuters is not responsible for the content in this press release.
SAN FRANCISCO--(Business Wire)-- The Mirion Technologies Health Physics Division announced it has received an order to supply a passive dosimetry system based upon Mirion`s patented Direct Ion Storage (DIS) technology to the Swedish Rescue Service Agency, which has been recently consolidated under the Swedish Civil Contingencies Agency. The system, which includes DIS-1 personal dosimeter badges and the DBR-1 dosimeter readers, will be distributed among several rescue units operating in the vicinity of Sweden`s nuclear power plants. The DIS-1 personal dosimeter, from Mirion`s RADOS product line, is well-suited for many radiation dosimetry applications. Small, rugged and waterproof, the DIS-1 can be read numerous times in a non-destructive manner without losing dose information. The DBR-1 dosimeter reader, also from Mirion`s RADOS product line, provides users with an instant dose reading and stores the dose in a buffer memory for subsequent electronic transmission. The instant reading capability allows the user to monitor dose on a daily basis, and the electronic transmission eliminates the need to send badges to a processing center to obtain an official dose of record. "We are pleased to provide our advanced dosimetry system to the Swedish Rescue Service Agency," said Antony Besso, President of Mirion`s Health Physics Division. "We look forward to a long-term partnership strengthening Sweden`s civil defense." ABOUT MIRION TECHNOLOGIES Mirion Technologies is a world leader in radiation detection, measuring and monitoring. Mirion has 13 facilities in Europe, Asia, and North America. Mirion Technologies is headquartered in the San Francisco Bay area and is a portfolio company of American Capital (NASDAQ:ACAS). Mirion Technologies Kimberly Croxson, 925-543-0806 kcroxson@mirion.com Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters